2025-08-29 14:09:57
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
Auro Laboratories Ltd posts Rs. 71.21 lakhs in Q2 FY2021-22
Posted On : 2021-11-12 15:58:16( TIMEZONE : IST )
AURO LABORATORIES LTD. has reported Standalone financial results for the period ended September 30, 2021.
Financial Results (Q2 FY2022) - QoQ Comparison
The company has reported total income of Rs. 10.6103 crores during the period ended September 30, 2021 as compared to Rs. 11.0254 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs. 0.7121 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 1.0665 crores for the period ended June 30, 2021.
The company has reported EPS of Rs. 1.14 for the period ended September 30, 2021 as compared to Rs. 1.71 for the period ended June 30, 2021.
| Financials | Q2 FY2022 | Q1 FY2022 | % Change |
| Total Income | ₹ 10.6103 crs | ₹11.0254 crs |  -3.76% |
| Net Profit | ₹0.7121 crs | ₹1.0665 crs | -33.23% |
| EPS | ₹1.14 | ₹1.71 | -33.33% |
Financial Results (Q2 FY2022) - YoY Comparison
The company has reported total income of Rs. 10.6103 crores during the period ended September 30, 2021 as compared to Rs.15.6323 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.0.7121 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.2.2540 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.1.14 for the period ended September 30, 2021 as compared to Rs.3.62 for the period ended September 30, 2020.
| Financials | Q2 FY2022 | Q2 FY2021 | % Change |
| Total Income | ₹ 10.6103 crs | ₹15.6323 crs | -32.13% |
| Net Profit | ₹0.7121 crs | ₹2.2540 crs | -68.41% |
| EPS | ₹1.14 | ₹3.62 | -68.51% |
Financial Results (Half Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.21.6357 crores during the 6 Months period ended September 30, 2021 as compared to Rs.27.9138 crores during the 6 Months period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.1.7786 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.3.6402 crores for the 6 Months period ended September 30, 2020.
The company has reported EPS of Rs.2.85 for the 6 Months period ended September 30, 2021 as compared to Rs.5.84 for the 6 Months period ended September 30, 2020.
| Financials | Half Year Ended FY2022 | Half Year Ended FY2021 | % Change |
| Total Income | ₹21.6357 crs | ₹27.9138 crs | -22.49% |
| Net Profit | ₹1.7786 crs | ₹3.6402 crs | -51.14% |
| EPS | ₹2.85 | ₹5.84 | -51.20% |
Shares of AURO LABORATORIES LTD. was last trading in BSE at Rs. 121.30 as compared to the previous close of Rs. 119.55. The total number of shares traded during the day was 4415 in over 87 trades.
The stock hit an intraday high of Rs. 125.45 and intraday low of 119.55. The net turnover during the day was Rs. 538087.00.
